{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T09:33:13Z","timestamp":1748338393746},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00115-021-01092-2","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T20:50:28Z","timestamp":1616705428000},"page":"293-306","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differenzialdiagnostik autoimmun-entz\u00fcndlicher R\u00fcckenmarkserkrankungen"],"prefix":"10.1007","volume":"92","author":[{"given":"Frederike C.","family":"Oertel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Scheel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Finke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/0961203309345730","volume":"18","author":"N Agmon-Levin","year":"2009","unstructured":"Agmon-Levin\u00a0N, Kivity\u00a0S, Szyper-Kravitz\u00a0M, Shoenfeld\u00a0Y (2009) Transverse myelitis and vaccines: a\u00a0multi-analysis. Lupus 18:1198\u20131204. https:\/\/doi.org\/10.1177\/0961203309345730","journal-title":"Lupus"},{"key":"1092_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji\u00a0A, Kidd\u00a0DP (2009) Neuro-Beh\u00e7et\u2019s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8:192\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(09)70015-8","journal-title":"Lancet Neurol"},{"key":"1092_CR3","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1212\/NXI.0000000000000343","volume":"4","author":"N Asgari","year":"2017","unstructured":"Asgari\u00a0N, Flanagan\u00a0EP, Fujihara\u00a0K et\u00a0al (2017) Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflammation 4:e343. https:\/\/doi.org\/10.1212\/NXI.0000000000000343","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2377-13-33","volume":"13","author":"N Asgari","year":"2013","unstructured":"Asgari\u00a0N, Skejoe\u00a0HPB, Lillevang\u00a0ST et al (2013) Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a\u00a0population-based, descriptive study. BMC Neurol 13:33. https:\/\/doi.org\/10.1186\/1471-2377-13-33","journal-title":"BMC Neurol"},{"key":"1092_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/2055217318796684","author":"S Asseyer","year":"2018","unstructured":"Asseyer\u00a0S, Schmidt\u00a0F, Chien\u00a0C et al (2018) Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders. Mult Scler J Exp Transl Clin. https:\/\/doi.org\/10.1177\/2055217318796684","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"1092_CR6","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1001\/archneur.1992.00530360094024","volume":"49","author":"L Averbuch-Heller","year":"1992","unstructured":"Averbuch-Heller\u00a0L, Steiner\u00a0I, Abramsky\u00a0O (1992) Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 49:1292\u20131295. https:\/\/doi.org\/10.1001\/archneur.1992.00530360094024","journal-title":"Arch Neurol"},{"key":"1092_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12016-017-8640-5","volume":"55","author":"J Bakshi","year":"2018","unstructured":"Bakshi\u00a0J, Segura\u00a0BT, Wincup\u00a0C, Rahman\u00a0A (2018) Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus. Clin Rev Allergy Immunol 55:352\u2013367. https:\/\/doi.org\/10.1007\/s12016-017-8640-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"1092_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/WNO.0000000000000732","volume":"38","author":"LJ Balcer","year":"2018","unstructured":"Balcer\u00a0LJ, Balk\u00a0LJ, Brandt\u00a0AU et\u00a0al (2018) The international multiple sclerosis visual system consortium: advancing visual system research in multiple sclerosis. J\u00a0Neuroophthalmol 38:494\u2013501. https:\/\/doi.org\/10.1097\/WNO.0000000000000732","journal-title":"J Neuroophthalmol"},{"key":"1092_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ncl.2012.09.008","volume":"31","author":"SC Beh","year":"2013","unstructured":"Beh\u00a0SC, Greenberg\u00a0BM, Frohman\u00a0T, Frohman\u00a0EM (2013) Transverse myelitis. Neurol Clin 31:79. https:\/\/doi.org\/10.1016\/j.ncl.2012.09.008","journal-title":"Neurol Clin"},{"key":"1092_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jocn.2018.11.046","volume":"61","author":"L-A Beume","year":"2019","unstructured":"Beume\u00a0L\u2011A, Wolf\u00a0K, Urbach\u00a0H et al (2019) Primary intraspinal non-Hodgkin\u2019s lymphoma: case report and review of literature. J\u00a0Clin Neurosci 61:262\u2013264. https:\/\/doi.org\/10.1016\/j.jocn.2018.11.046","journal-title":"J Clin Neurosci"},{"key":"1092_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/BOR.0000000000000564","volume":"31","author":"AC Billi","year":"2019","unstructured":"Billi\u00a0AC, Kahlenberg\u00a0JM, Gudjonsson\u00a0JE (2019) Sex bias in autoimmunity. Curr Opin Rheumatol 31:53\u201361. https:\/\/doi.org\/10.1097\/BOR.0000000000000564","journal-title":"Curr Opin Rheumatol"},{"key":"1092_CR12","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1002\/art.24937","volume":"60","author":"J Birnbaum","year":"2009","unstructured":"Birnbaum\u00a0J, Petri\u00a0M, Thompson\u00a0R et\u00a0al (2009) Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheum 60:3378\u20133387. https:\/\/doi.org\/10.1002\/art.24937","journal-title":"Arthritis Rheum"},{"key":"1092_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/BF01451059","volume":"17","author":"G Bolla","year":"1998","unstructured":"Bolla\u00a0G, Disdier\u00a0P, Verrot\u00a0D et\u00a0al (1998) Acute transverse myelitis and primary urticarial vasculitis. Clin Rheumatol 17:250\u2013252. https:\/\/doi.org\/10.1007\/BF01451059","journal-title":"Clin Rheumatol"},{"key":"1092_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1212\/wnl.62.2.226","volume":"62","author":"JCJ Bot","year":"2004","unstructured":"Bot\u00a0JCJ, Barkhof\u00a0F, Polman\u00a0CH et\u00a0al (2004) Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62:226\u2013233. https:\/\/doi.org\/10.1212\/wnl.62.2.226","journal-title":"Neurology"},{"key":"1092_CR15","volume-title":"Localization in clinical neurology","author":"PW Brazis","year":"2012","unstructured":"Brazis\u00a0PW, Masdeu\u00a0JC, Biller\u00a0J (2012) Localization in clinical neurology. Lippincott Williams & Wilkins,"},{"key":"1092_CR16","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/mds.22821","volume":"24","author":"K B\u00fcrk","year":"2009","unstructured":"B\u00fcrk\u00a0K, Farecki\u00a0M\u2011L, Lamprecht\u00a0G et al (2009) Neurological symptoms in patients with biopsy proven celiac disease. Mov Disord 24:2358\u20132362. https:\/\/doi.org\/10.1002\/mds.22821","journal-title":"Mov Disord"},{"key":"1092_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.1127","volume":"50","author":"KH Chan","year":"2001","unstructured":"Chan\u00a0KH, Vernino\u00a0S, Lennon\u00a0VA (2001) ANNA\u20113 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 50:301\u2013311. https:\/\/doi.org\/10.1002\/ana.1127","journal-title":"Ann Neurol"},{"key":"1092_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518815596","author":"C Chien","year":"2018","unstructured":"Chien\u00a0C, Scheel\u00a0M, Schmitz-H\u00fcbsch\u00a0T et al (2018) Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity. Mult Scler. https:\/\/doi.org\/10.1177\/1352458518815596","journal-title":"Mult Scler"},{"key":"1092_CR19","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1212\/NXI.0000000000000543","volume":"6","author":"A Cobo-Calvo","year":"2019","unstructured":"Cobo-Calvo\u00a0A, Ayrignac\u00a0X, Kerschen\u00a0P et al (2019) Cranial nerve involvement in patients with MOG antibody-associated disease. Neurol Neuroimmunol Neuroinflammation 6:e543. https:\/\/doi.org\/10.1212\/NXI.0000000000000543","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR20","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000649","author":"\u00c1 Cobo-Calvo","year":"2020","unstructured":"Cobo-Calvo \u00c1, d\u2019Indy\u00a0H, Ruiz\u00a0A et al (2020) Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: a multicenter cross-sectional study. Neurol Neuroimmunol Neuroinflammation. https:\/\/doi.org\/10.1212\/NXI.0000000000000649","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR21","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1152\/japplphysiol.00460.2010","volume":"109","author":"SL Davis","year":"2010","unstructured":"Davis\u00a0SL, Wilson\u00a0TE, White\u00a0AT, Frohman\u00a0EM (2010) Thermoregulation in multiple sclerosis. J\u00a0Appl Physiol 109:1531\u20131537. https:\/\/doi.org\/10.1152\/japplphysiol.00460.2010","journal-title":"J Appl Physiol"},{"key":"1092_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fimmu.2019.00726","volume":"10","author":"F Deisenhammer","year":"2019","unstructured":"Deisenhammer\u00a0F, Zetterberg\u00a0H, Fitzner\u00a0B, Zettl\u00a0UK (2019) The cerebrospinal fluid in multiple sclerosis. Front Immunol 10:726. https:\/\/doi.org\/10.3389\/fimmu.2019.00726","journal-title":"Front Immunol"},{"key":"1092_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande\u00a0S, de Seze\u00a0J, Fauchais\u00a0A\u2011L et al (2004) Neurologic manifestations in primary Sj\u00f6gren syndrome: a\u00a0study of 82\u00a0patients. Medicine 83:280\u2013291. https:\/\/doi.org\/10.1097\/01.md.0000141099.53742.16","journal-title":"Medicine"},{"key":"1092_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","volume":"46","author":"M Den\u00e8ve","year":"2019","unstructured":"Den\u00e8ve\u00a0M, Biotti\u00a0D, Patsoura\u00a0S et al (2019) MRI features of demyelinating disease associated with anti-MOG antibodies in adults. J\u00a0Neuroradiol 46:312\u2013318. https:\/\/doi.org\/10.1016\/j.neurad.2019.06.001","journal-title":"J Neuroradiol"},{"key":"1092_CR25","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande\u00a0V, Zen\u00a0Y, Chan\u00a0JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181\u20131192. https:\/\/doi.org\/10.1038\/modpathol.2012.72","journal-title":"Mod Pathol"},{"key":"1092_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","volume":"321","author":"D Dubey","year":"2018","unstructured":"Dubey\u00a0D, Hinson\u00a0SR, Jolliffe\u00a0EA et\u00a0al (2018) Autoimmune GFAP astrocytopathy: prospective evaluation of 90\u00a0patients in 1\u00a0year. J\u00a0Neuroimmunol 321:157\u2013163. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.016","journal-title":"J Neuroimmunol"},{"key":"1092_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","volume":"76","author":"D Dubey","year":"2019","unstructured":"Dubey\u00a0D, Pittock\u00a0SJ, Krecke\u00a0KN et\u00a0al (2019) Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol 76:301. https:\/\/doi.org\/10.1001\/jamaneurol.2018.4053","journal-title":"JAMA Neurol"},{"key":"1092_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00415-016-8092-5","volume":"263","author":"C-A Durel","year":"2016","unstructured":"Durel\u00a0C\u2011A, Marignier\u00a0R, Maucort-Boulch\u00a0D et al (2016) Clinical features and prognostic factors of spinal cord sarcoidosis: a\u00a0multicenter observational study of 20 BIOPSY-PROVEN patients. J\u00a0Neurol 263:981\u2013990. https:\/\/doi.org\/10.1007\/s00415-016-8092-5","journal-title":"J Neurol"},{"key":"1092_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/bmj.1.5904.394-b","volume":"1","author":"MA Edgar","year":"1974","unstructured":"Edgar\u00a0MA (1974) Letter: nervous system involvement in ankylosing spondylitis. Br Med\u00a0J 1:394. https:\/\/doi.org\/10.1136\/bmj.1.5904.394-b","journal-title":"Br Med J"},{"key":"1092_CR30","doi-asserted-by":"publisher","first-page":"e0223897","DOI":"10.1371\/journal.pone.0223897","volume":"14","author":"LEM Eurelings","year":"2019","unstructured":"Eurelings\u00a0LEM, Miedema\u00a0JR, Dalm\u00a0VASH et al (2019) Sensitivity and specificity of serum soluble interleukin\u20112 receptor for diagnosing sarcoidosis in a\u00a0population of patients suspected of sarcoidosis. PLoS ONE 14:e223897. https:\/\/doi.org\/10.1371\/journal.pone.0223897","journal-title":"PLoS ONE"},{"key":"1092_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","volume":"15","author":"M Filippi","year":"2016","unstructured":"Filippi\u00a0M, Rocca\u00a0MA, Ciccarelli\u00a0O et\u00a0al (2016) MRI criteria for the diagnosis of multiple sclerosis: magnims consensus guidelines. Lancet Neurol 15:292\u2013303. https:\/\/doi.org\/10.1016\/S1474-4422(15)00393-2","journal-title":"Lancet Neurol"},{"key":"1092_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/omcr\/omv015","volume":"2015","author":"C Finke","year":"2015","unstructured":"Finke\u00a0C, Schmidt\u00a0W, Siebert\u00a0E, Ostendorf\u00a0F (2015) Etanercept-associated myelitis. Oxf Med Case Rep 2015:220\u2013221. https:\/\/doi.org\/10.1093\/omcr\/omv015","journal-title":"Oxf Med Case Rep"},{"key":"1092_CR33","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1378\/chest.08-2839","volume":"136","author":"A Fischer","year":"2009","unstructured":"Fischer\u00a0A, Swigris\u00a0JJ, du Bois\u00a0RM et\u00a0al (2009) Minor salivary gland biopsy to detect primary Sj\u00f6gren syndrome in patients with interstitial lung disease. Chest 136:1072\u20131078. https:\/\/doi.org\/10.1378\/chest.08-2839","journal-title":"Chest"},{"key":"1092_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ncl.2012.09.001","volume":"31","author":"EP Flanagan","year":"2013","unstructured":"Flanagan\u00a0EP, Keegan\u00a0BM (2013) Paraneoplastic myelopathy. Neurol Clin 31:307\u2013318. https:\/\/doi.org\/10.1016\/j.ncl.2012.09.001","journal-title":"Neurol Clin"},{"key":"1092_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","volume":"72","author":"EP Flanagan","year":"2015","unstructured":"Flanagan\u00a0EP, Weinshenker\u00a0BG, Krecke\u00a0KN et al (2015) Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol 72:81\u201387. https:\/\/doi.org\/10.1001\/jamaneurol.2014.2137","journal-title":"JAMA Neurol"},{"key":"1092_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMcp1001112","volume":"363","author":"EM Frohman","year":"2010","unstructured":"Frohman\u00a0EM, Wingerchuk\u00a0DM (2010) Clinical practice. Transverse myelitis. N\u00a0Engl J Med 363:564\u2013572. https:\/\/doi.org\/10.1056\/NEJMcp1001112","journal-title":"N Engl J Med"},{"key":"1092_CR37","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1177\/1352458517731911","volume":"24","author":"M Gastaldi","year":"2018","unstructured":"Gastaldi\u00a0M, Marchioni\u00a0E, Banfi\u00a0P et\u00a0al (2018) Predictors of outcome in a\u00a0large retrospective cohort of patients with transverse myelitis. Mult Scler 24:1743\u20131752. https:\/\/doi.org\/10.1177\/1352458517731911","journal-title":"Mult Scler"},{"key":"1092_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrneurol.2018.14","volume":"14","author":"R Geraldes","year":"2018","unstructured":"Geraldes\u00a0R, Ciccarelli\u00a0O, Barkhof\u00a0F et\u00a0al (2018) The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol 14:199\u2013213. https:\/\/doi.org\/10.1038\/nrneurol.2018.14","journal-title":"Nat Rev Neurol"},{"key":"1092_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00281-018-0723-8","volume":"41","author":"SM Gold","year":"2019","unstructured":"Gold\u00a0SM, Willing\u00a0A, Leypoldt\u00a0F et\u00a0al (2019) Sex differences in autoimmune disorders of the central nervous system. Semin Immunopathol 41:177\u2013188. https:\/\/doi.org\/10.1007\/s00281-018-0723-8","journal-title":"Semin Immunopathol"},{"key":"1092_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/01.CON.0000461086.79241.3b","volume":"21","author":"BP Goodman","year":"2015","unstructured":"Goodman\u00a0BP (2015) Metabolic and toxic causes of myelopathy. Contin Minneap Minn 21:84\u201399. https:\/\/doi.org\/10.1212\/01.CON.0000461086.79241.3b","journal-title":"Contin Minneap Minn"},{"key":"1092_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","volume":"75","author":"SHM Hamid","year":"2018","unstructured":"Hamid\u00a0SHM, Whittam\u00a0D, Saviour\u00a0M et\u00a0al (2018) Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease. JAMA Neurol 75:65\u201371. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3196","journal-title":"JAMA Neurol"},{"key":"1092_CR42","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000856","author":"DA H\u00e4ring","year":"2020","unstructured":"H\u00e4ring\u00a0DA, Kropshofer\u00a0H, Kappos\u00a0L et al (2020) Long-term prognostic value of longitudinal measurements of blood neurofilament levels. Neurol Neuroimmunol Neuroinflammation. https:\/\/doi.org\/10.1212\/NXI.0000000000000856","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp.2007.118588","volume":"79","author":"LA Hoffmann","year":"2008","unstructured":"Hoffmann\u00a0LA, Jarius\u00a0S, Pellkofer\u00a0HL et al (2008) Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J\u00a0Neurol Neurosurg Psychiatry 79:767\u2013773. https:\/\/doi.org\/10.1136\/jnnp.2007.118588","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1092_CR44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/CCO.0000000000000222","volume":"27","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger\u00a0R, Rosenfeld\u00a0MR, Dalmau\u00a0J (2015) Update on neurological paraneoplastic syndromes. Curr Opin Oncol 27:489\u2013495. https:\/\/doi.org\/10.1097\/CCO.0000000000000222","journal-title":"Curr Opin Oncol"},{"key":"1092_CR45","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ncl.2016.06.016","volume":"34","author":"J Howard","year":"2016","unstructured":"Howard\u00a0J, Trevick\u00a0S, Younger\u00a0DS (2016) Epidemiology of multiple sclerosis. Neurol Clin 34:919\u2013939. https:\/\/doi.org\/10.1016\/j.ncl.2016.06.016","journal-title":"Neurol Clin"},{"key":"1092_CR46","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515613642","author":"L Hyung Seok","year":"2016","unstructured":"Hyung Seok\u00a0L, Do Young\u00a0K, Ha Young\u00a0S, Young-Chul\u00a0C, Seung Min\u00a0K (2016) Spinal cord involvement in Beh\u00e7et\u2019s disease. Mult Scler. https:\/\/doi.org\/10.1177\/1352458515613642","journal-title":"Mult Scler"},{"key":"1092_CR47","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.jocn.2008.05.002","volume":"15","author":"W Huynh","year":"2008","unstructured":"Huynh\u00a0W, Cordato\u00a0DJ, Kehdi\u00a0E et al (2008) Post-vaccination encephalomyelitis: literature review and illustrative case. J\u00a0Clin Neurosci 15:1315\u20131322. https:\/\/doi.org\/10.1016\/j.jocn.2008.05.002","journal-title":"J Clin Neurosci"},{"key":"1092_CR48","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","volume":"89","author":"R Iorio","year":"2018","unstructured":"Iorio\u00a0R, Damato\u00a0V, Evoli\u00a0A et\u00a0al (2018) Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a\u00a0case series of 22\u00a0patients. J\u00a0Neurol Neurosurg Psychiatry 89:138\u2013146. https:\/\/doi.org\/10.1136\/jnnp-2017-316583","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1092_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius\u00a0S, Paul\u00a0F, Franciotta\u00a0D et al (2011) Cerebrospinal fluid findings in aquaporin\u20114 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J\u00a0Neurol Sci 306:82\u201390. https:\/\/doi.org\/10.1016\/j.jns.2011.03.038","journal-title":"J Neurol Sci"},{"key":"1092_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0","author":"S Jarius","year":"2016","unstructured":"Jarius\u00a0S, Ruprecht\u00a0K, Kleiter\u00a0I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50\u00a0patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J\u00a0Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"1092_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius\u00a0S, Ruprecht\u00a0K, Kleiter\u00a0I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50\u00a0patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J\u00a0Neuroinflammation 13:279. https:\/\/doi.org\/10.1186\/s12974-016-0717-1","journal-title":"J Neuroinflammation"},{"key":"1092_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius\u00a0S, Wildemann\u00a0B, Paul\u00a0F (2014) Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 176:149\u2013164. https:\/\/doi.org\/10.1111\/cei.12271","journal-title":"Clin Exp Immunol"},{"key":"1092_CR53","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.25068","volume":"82","author":"JME Jende","year":"2017","unstructured":"Jende\u00a0JME, Hauck\u00a0GH, Diem\u00a0R et\u00a0al (2017) Peripheral nerve involvement in multiple sclerosis: demonstration by magnetic resonance neurography. Ann Neurol 82:676\u2013685. https:\/\/doi.org\/10.1002\/ana.25068","journal-title":"Ann Neurol"},{"key":"1092_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneurol.2015.80","volume":"11","author":"H Kearney","year":"2015","unstructured":"Kearney\u00a0H, Miller\u00a0DH, Ciccarelli\u00a0O (2015) Spinal cord MRI in multiple sclerosis\u2014diagnostic, prognostic and clinical value. Nat Rev Neurol 11:327\u2013338. https:\/\/doi.org\/10.1038\/nrneurol.2015.80","journal-title":"Nat Rev Neurol"},{"key":"1092_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jocn.2007.05.002","volume":"15","author":"PA Kempster","year":"2008","unstructured":"Kempster\u00a0PA, Rollinson\u00a0RD (2008) The Lhermitte phenomenon: variant forms and their significance. J\u00a0Clin Neurosci 15:379\u2013381. https:\/\/doi.org\/10.1016\/j.jocn.2007.05.002","journal-title":"J Clin Neurosci"},{"key":"1092_CR56","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000708","author":"H Kim","year":"2020","unstructured":"Kim\u00a0H, Lee\u00a0E\u2011J, Kim\u00a0S et al (2020) Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease. Neurol Neuroimmunol Neuroinflammation. https:\/\/doi.org\/10.1212\/NXI.0000000000000708","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ncl.2006.11.001","volume":"25","author":"N Kumar","year":"2007","unstructured":"Kumar\u00a0N (2007) Nutritional neuropathies. Neurol Clin 25:209\u2013255. https:\/\/doi.org\/10.1016\/j.ncl.2006.11.001","journal-title":"Neurol Clin"},{"key":"1092_CR58","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1212\/01.wnl.0000208510.76323.5b","volume":"66","author":"N Kumar","year":"2006","unstructured":"Kumar\u00a0N, Cohen-Gadol\u00a0AA, Wright\u00a0RA et al (2006) Superficial siderosis. Neurology 66:1144\u20131152. https:\/\/doi.org\/10.1212\/01.wnl.0000208510.76323.5b","journal-title":"Neurology"},{"key":"1092_CR59","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/jnnp.2005.086140","volume":"77","author":"F Leypoldt","year":"2006","unstructured":"Leypoldt\u00a0F, Eichhorn\u00a0P, Saager\u00a0C et al (2006) Successful immunosuppressive treatment and long-term follow-up of anti-Ri-associated paraneoplastic myelitis. J\u00a0Neurol Neurosurg Psychiatry 77:1199\u20131200. https:\/\/doi.org\/10.1136\/jnnp.2005.086140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1092_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jneuroim.2019.03.001","volume":"330","author":"Z Liu","year":"2019","unstructured":"Liu\u00a0Z, Jiao\u00a0L, Qiu\u00a0Z et\u00a0al (2019) Clinical characteristics of patients with paraneoplastic myelopathy. J\u00a0Neuroimmunol 330:136\u2013142. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.03.001","journal-title":"J Neuroimmunol"},{"key":"1092_CR61","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/archneurol.2011.128","volume":"68","author":"A McKeon","year":"2011","unstructured":"McKeon\u00a0A (2011) Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol 68:1282. https:\/\/doi.org\/10.1001\/archneurol.2011.128","journal-title":"Arch Neurol"},{"key":"1092_CR62","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-011-0876-1","volume":"122","author":"A McKeon","year":"2011","unstructured":"McKeon\u00a0A, Pittock\u00a0SJ (2011) Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol 122:381\u2013400. https:\/\/doi.org\/10.1007\/s00401-011-0876-1","journal-title":"Acta Neuropathol"},{"key":"1092_CR63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/NRL.0b013e31815ac523","volume":"14","author":"M Mehling","year":"2008","unstructured":"Mehling\u00a0M, Kuhle\u00a0J, Regeniter\u00a0A (2008) 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system. Neurologist 14:60\u201365. https:\/\/doi.org\/10.1097\/NRL.0b013e31815ac523","journal-title":"Neurologist"},{"key":"1092_CR64","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1212\/wnl.60.3.517","volume":"60","author":"S Moskau","year":"2003","unstructured":"Moskau\u00a0S, Urbach\u00a0H, Hartmann\u00a0A, Schmidt\u00a0S (2003) Multifocal myelitis in Beh\u00e7et\u2019s disease. Neurology 60:517. https:\/\/doi.org\/10.1212\/wnl.60.3.517","journal-title":"Neurology"},{"key":"1092_CR65","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1212\/NXI.0000000000000722","volume":"7","author":"OC Murphy","year":"2020","unstructured":"Murphy\u00a0OC, Salazar-Camelo\u00a0A, Jimenez\u00a0JA et al (2020) Clinical and MRI phenotypes of sarcoidosis-associated myelopathy. Neurol Neuroimmunol Neuroinflammation 7:e722. https:\/\/doi.org\/10.1212\/NXI.0000000000000722","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04822-7","author":"T Nakamura","year":"2020","unstructured":"Nakamura\u00a0T, Kaneko\u00a0K, Watanabe\u00a0G et al (2020) Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04822-7","journal-title":"Neurol Sci"},{"key":"1092_CR67","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/s0022-510x(98)00073-2","volume":"157","author":"I Nakashima","year":"1998","unstructured":"Nakashima\u00a0I, Fujihara\u00a0K, Endo\u00a0M et al (1998) Clinical and laboratory features of myelitis patients with anti-neutrophil cytoplasmic antibodies. J\u00a0Neurol Sci 157:60\u201366. https:\/\/doi.org\/10.1016\/s0022-510x(98)00073-2","journal-title":"J Neurol Sci"},{"key":"1092_CR68","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","volume":"25","author":"R Narayan","year":"2018","unstructured":"Narayan\u00a0R, Simpson\u00a0A, Fritsche\u00a0K et\u00a0al (2018) MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 25:66\u201372. https:\/\/doi.org\/10.1016\/j.msard.2018.07.025","journal-title":"Mult Scler Relat Disord"},{"key":"1092_CR69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13167-017-0123-5","volume":"9","author":"FC Oertel","year":"2018","unstructured":"Oertel\u00a0FC, Zimmermann\u00a0H, Paul\u00a0F, Brandt\u00a0AU (2018) Optical coherence tomography in neuromyelitis optica spectrum disorders: Potential advantages for individualized monitoring of progression and therapy. EPMA\u00a0J 9:21\u201333. https:\/\/doi.org\/10.1007\/s13167-017-0123-5","journal-title":"EPMA J"},{"key":"1092_CR70","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","volume":"4","author":"R Ogawa","year":"2017","unstructured":"Ogawa\u00a0R, Nakashima\u00a0I, Takahashi\u00a0T et al (2017) MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflammation 4:e322. https:\/\/doi.org\/10.1212\/NXI.0000000000000322","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR71","doi-asserted-by":"publisher","first-page":"ITC5-1","DOI":"10.7326\/0003-4819-156-9-201205010-01005","volume":"156","author":"A O\u2019Regan","year":"2012","unstructured":"O\u2019Regan\u00a0A, Berman\u00a0JS, Cotton\u00a0D et al (2012) Sarcoidosis. Ann Intern Med 156:ITC5\u20111. https:\/\/doi.org\/10.7326\/0003-4819-156-9-201205010-01005","journal-title":"Ann Intern Med"},{"key":"1092_CR72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00401-002-0645-2","volume":"105","author":"M Osoegawa","year":"2003","unstructured":"Osoegawa\u00a0M, Ochi\u00a0H, Kikuchi\u00a0H et\u00a0al (2003) Eosinophilic myelitis associated with atopic diathesis: a\u00a0combined neuroimaging and histopathological study. Acta Neuropathol 105:289\u2013295. https:\/\/doi.org\/10.1007\/s00401-002-0645-2","journal-title":"Acta Neuropathol"},{"key":"1092_CR73","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515591069","author":"Y Pekcevik","year":"2015","unstructured":"Pekcevik\u00a0Y, Mitchell\u00a0CH, Mealy\u00a0MA et\u00a0al (2015) Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging. Mult Scler\u00a0J. https:\/\/doi.org\/10.1177\/1352458515591069","journal-title":"Mult Scler J"},{"key":"1092_CR74","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold\u00a0A, Balcer\u00a0LJ, Calabresi\u00a0PA et al (2017) Retinal layer segmentation in multiple sclerosis: a\u00a0systematic review and meta-analysis. Lancet Neurol 16:797\u2013812. https:\/\/doi.org\/10.1016\/S1474-4422(17)30278-8","journal-title":"Lancet Neurol"},{"key":"1092_CR75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.20529","volume":"58","author":"SJ Pittock","year":"2005","unstructured":"Pittock\u00a0SJ, Lucchinetti\u00a0CF, Parisi\u00a0JE et\u00a0al (2005) Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 58:96\u2013107. https:\/\/doi.org\/10.1002\/ana.20529","journal-title":"Ann Neurol"},{"key":"1092_CR76","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4065\/81.9.1207","volume":"81","author":"SJ Pittock","year":"2006","unstructured":"Pittock\u00a0SJ, Yoshikawa\u00a0H, Ahlskog\u00a0JE et\u00a0al (2006) Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 81:1207\u20131214. https:\/\/doi.org\/10.4065\/81.9.1207","journal-title":"Mayo Clin Proc"},{"key":"1092_CR77","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00415-009-5361-6","volume":"257","author":"JJG Rath","year":"2010","unstructured":"Rath\u00a0JJG, Ronday\u00a0HK, Wirtz\u00a0PW (2010) Acute transverse myelitis in psoriatic arthritis. J\u00a0Neurol 257:457\u2013458. https:\/\/doi.org\/10.1007\/s00415-009-5361-6","journal-title":"J Neurol"},{"key":"1092_CR78","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/rheumatology\/32.12.1105","volume":"32","author":"DW Ray","year":"1993","unstructured":"Ray\u00a0DW, Bridger\u00a0J, Hawnaur\u00a0J et al (1993) Transverse myelitis as the presentation of Jo\u20111 antibody syndrome (myositis and fibrosing alveolitis) in long-standing ulcerative colitis. Br J Rheumatol 32:1105\u20131108. https:\/\/doi.org\/10.1093\/rheumatology\/32.12.1105","journal-title":"Br J Rheumatol"},{"key":"1092_CR79","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000674","author":"M Reindl","year":"2020","unstructured":"Reindl\u00a0M, Schanda\u00a0K, Woodhall\u00a0M et\u00a0al (2020) International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflammation. https:\/\/doi.org\/10.1212\/NXI.0000000000000674","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR80","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/sj.bmt.1702677","volume":"26","author":"S Richard","year":"2000","unstructured":"Richard\u00a0S, Fruchtman\u00a0S, Scigliano\u00a0E et\u00a0al (2000) An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a\u00a0patient with severe aplastic anemia. Bone Marrow Transplant 26:1225\u20131228. https:\/\/doi.org\/10.1038\/sj.bmt.1702677","journal-title":"Bone Marrow Transplant"},{"key":"1092_CR81","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000924","author":"S Rinaldi","year":"2021","unstructured":"Rinaldi\u00a0S, Davies\u00a0A, Fehmi\u00a0J et al (2021) Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders. Neurol Neuroimmunol Neuroinflammation. https:\/\/doi.org\/10.1212\/NXI.0000000000000924","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR82","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/1352458513503053","volume":"20","author":"M Ringelstein","year":"2014","unstructured":"Ringelstein\u00a0M, Kleiter\u00a0I, Ayzenberg\u00a0I et\u00a0al (2014) Visual evoked potentials in neuromyelitis optica and its spectrum disorders. Mult Scler 20:617\u2013620. https:\/\/doi.org\/10.1177\/1352458513503053","journal-title":"Mult Scler"},{"key":"1092_CR83","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1177\/1352458513510981","volume":"20","author":"M Ringelstein","year":"2014","unstructured":"Ringelstein\u00a0M, Metz\u00a0I, Ruprecht\u00a0K et al (2014) Contribution of spinal cord biopsy to diagnosis of aquaporin\u20114 antibody positive neuromyelitis optica spectrum disorder. Mult Scler 20:882\u2013888. https:\/\/doi.org\/10.1177\/1352458513510981","journal-title":"Mult Scler"},{"key":"1092_CR84","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semarthrit.2010.05.004","volume":"40","author":"CEM Rodrigues","year":"2011","unstructured":"Rodrigues\u00a0CEM, de Carvalho\u00a0JF (2011) Clinical, radiologic, and therapeutic analysis of 14\u00a0patients with transverse myelitis associated with antiphospholipid syndrome: report of 4\u00a0cases and review of the literature. Semin Arthritis Rheum 40:349\u2013357. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.05.004","journal-title":"Semin Arthritis Rheum"},{"key":"1092_CR85","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archopht.1996.01100130585016","volume":"114","author":"A Rodriguez","year":"1996","unstructured":"Rodriguez\u00a0A, Calonge\u00a0M, Pedroza-Seres\u00a0M et al (1996) Referral patterns of uveitis in a\u00a0tertiary eye care center. Arch Ophthalmol 114:593\u2013599. https:\/\/doi.org\/10.1001\/archopht.1996.01100130585016","journal-title":"Arch Ophthalmol"},{"key":"1092_CR86","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519893093","author":"S Salama","year":"2020","unstructured":"Salama\u00a0S, Khan\u00a0M, Shanechi\u00a0A et\u00a0al (2020) MRI differences between MOG antibody disease and AQP4 NMOSD. Mult Scler. https:\/\/doi.org\/10.1177\/1352458519893093","journal-title":"Mult Scler"},{"key":"1092_CR87","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.mayocp.2019.01.047","volume":"94","author":"F Savoldi","year":"2019","unstructured":"Savoldi\u00a0F, Nasr\u00a0Z, Hu\u00a0W et\u00a0al (2019) McArdle sign: a specific sign of multiple sclerosis. Mayo Clin Proc 94:1427\u20131435. https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.047","journal-title":"Mayo Clin Proc"},{"key":"1092_CR88","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00415-002-0706-4","volume":"249","author":"P Sillevis Smitt","year":"2002","unstructured":"Sillevis Smitt\u00a0P, Grefkens\u00a0J, de Leeuw\u00a0B et al (2002) Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis\/sensory neuronopathy. J\u00a0Neurol 249:745\u2013753. https:\/\/doi.org\/10.1007\/s00415-002-0706-4","journal-title":"J Neurol"},{"key":"1092_CR89","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1212\/NXI.0000000000000252","volume":"3","author":"K Soelberg","year":"2016","unstructured":"Soelberg\u00a0K, Larsen\u00a0SR, Moerch\u00a0MT et al (2016) Aquaporin\u20114 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer. Neurol Neuroimmunol Neuroinflammation 3:e252. https:\/\/doi.org\/10.1212\/NXI.0000000000000252","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR90","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","volume":"3","author":"M Spadaro","year":"2016","unstructured":"Spadaro\u00a0M, Gerdes\u00a0LA, Krumbholz\u00a0M et\u00a0al (2016) Autoantibodies to MOG in a\u00a0distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflammation 3:e257. https:\/\/doi.org\/10.1212\/NXI.0000000000000257","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR91","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1212\/01.wnl.0000326589.57128.c3","volume":"71","author":"M Tanaka","year":"2008","unstructured":"Tanaka\u00a0M, Matsushita\u00a0T, Tateishi\u00a0T et\u00a0al (2008) Distinct CSF cytokine\/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 71:974\u2013981. https:\/\/doi.org\/10.1212\/01.wnl.0000326589.57128.c3","journal-title":"Neurology"},{"key":"1092_CR92","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1212\/01.wnl.0000259404.51352.7f","volume":"68","author":"S Tenembaum","year":"2007","unstructured":"Tenembaum\u00a0S, Chitnis\u00a0T, Ness\u00a0J et\u00a0al (2007) Acute disseminated encephalomyelitis. Neurology 68:S23\u2013S36. https:\/\/doi.org\/10.1212\/01.wnl.0000259404.51352.7f","journal-title":"Neurology"},{"key":"1092_CR93","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson\u00a0AJ, Banwell\u00a0BL, Barkhof\u00a0F et\u00a0al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"1092_CR94","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/wnl.59.4.499","volume":"59","author":"Transverse Myelitis Consortium Working Group","year":"2002","unstructured":"Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499\u2013505. https:\/\/doi.org\/10.1212\/wnl.59.4.499","journal-title":"Neurology"},{"key":"1092_CR95","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1212\/WNL.0000000000005853","volume":"91","author":"C Tsagkas","year":"2018","unstructured":"Tsagkas\u00a0C, Magon\u00a0S, Gaetano\u00a0L et\u00a0al (2018) Spinal cord volume loss: a marker of disease progression in multiple sclerosis. Neurology 91:e349\u2013e358. https:\/\/doi.org\/10.1212\/WNL.0000000000005853","journal-title":"Neurology"},{"key":"1092_CR96","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4","volume":"47","author":"S Vernino","year":"2000","unstructured":"Vernino\u00a0S, Lennon\u00a0VA (2000) New Purkinje cell antibody (PCA-2): Marker of lung cancer\u2013related neurological autoimmunity. Ann Neurol 47:297\u2013305. https:\/\/doi.org\/10.1002\/1531-8249(200003)47:3\u3008297::AID-ANA4\u30093.0.CO;2-4","journal-title":"Ann Neurol"},{"key":"1092_CR97","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ana.20614","volume":"58","author":"R Vitaliani","year":"2005","unstructured":"Vitaliani\u00a0R, Mason\u00a0W, Ances\u00a0B et\u00a0al (2005) Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58:594\u2013604. https:\/\/doi.org\/10.1002\/ana.20614","journal-title":"Ann Neurol"},{"key":"1092_CR98","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/WCO.0000000000000684","volume":"32","author":"M Voortman","year":"2019","unstructured":"Voortman\u00a0M, Drent\u00a0M, Baughman\u00a0RP (2019) Management of neurosarcoidosis: a\u00a0clinical challenge. Curr Opin Neurol 32:475\u2013483. https:\/\/doi.org\/10.1097\/WCO.0000000000000684","journal-title":"Curr Opin Neurol"},{"key":"1092_CR99","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/art.27337","volume":"62","author":"K-P Wandinger","year":"2010","unstructured":"Wandinger\u00a0K\u2011P, Stangel\u00a0M, Witte\u00a0T et al (2010) Autoantibodies against aquaporin\u20114 in patients with neuropsychiatric systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 62:1198\u20131200. https:\/\/doi.org\/10.1002\/art.27337","journal-title":"Arthritis Rheum"},{"key":"1092_CR100","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","volume":"93","author":"M Watanabe","year":"2019","unstructured":"Watanabe\u00a0M, Nakamura\u00a0Y, Michalak\u00a0Z et\u00a0al (2019) Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Neurology 93:e1299\u2013e1311. https:\/\/doi.org\/10.1212\/WNL.0000000000008160","journal-title":"Neurology"},{"key":"1092_CR101","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","volume":"87","author":"P Waters","year":"2016","unstructured":"Waters\u00a0P, Reindl\u00a0M, Saiz\u00a0A et al (2016) Multicentre comparison of a\u00a0diagnostic assay: aquaporin\u20114 antibodies in neuromyelitis optica. J\u00a0Neurol Neurosurg Psychiatry 87:1005\u20131015. https:\/\/doi.org\/10.1136\/jnnp-2015-312601","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1092_CR102","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/jnnp.68.4.532a","volume":"68","author":"SJ Weatherby","year":"2000","unstructured":"Weatherby\u00a0SJ, Davies\u00a0MB, Hawkins\u00a0CP et\u00a0al (2000) Transverse myelopathy, a\u00a0rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy. J\u00a0Neurol Neurosurg Psychiatry 68:532\u2013533. https:\/\/doi.org\/10.1136\/jnnp.68.4.532a","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1092_CR103","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000670","author":"J Wickel","year":"2020","unstructured":"Wickel\u00a0J, Chung\u00a0H\u2011Y, Kirchhof\u00a0K et al (2020) Encephalitis with radial perivascular emphasis: not necessarily associated with GFAP antibodies. Neurol Neuroimmunol Neuroinflammation. https:\/\/doi.org\/10.1212\/NXI.0000000000000670","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"1092_CR104","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3171\/2016.5.SPINE16119","volume":"26","author":"MM Williams","year":"2017","unstructured":"Williams\u00a0MM, Mashaly\u00a0H, Puduvalli\u00a0VK et\u00a0al (2017) Immunoglobulin G4\u2013related disease mimicking an epidural spinal cord tumor: case report. J\u00a0Neurosurg Spine 26:76\u201380. https:\/\/doi.org\/10.3171\/2016.5.SPINE16119","journal-title":"J Neurosurg Spine"},{"key":"1092_CR105","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk\u00a0DM, Banwell\u00a0B, Bennett\u00a0JL et\u00a0al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"1092_CR106","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/1352458513495581","volume":"20","author":"T Yonezu","year":"2014","unstructured":"Yonezu\u00a0T, Ito\u00a0S, Mori\u00a0M et\u00a0al (2014) \u201cBright spotty lesions\u201d on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler 20:331\u2013337. https:\/\/doi.org\/10.1177\/1352458513495581","journal-title":"Mult Scler"},{"key":"1092_CR107","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu\u00a0Z, Kryzer\u00a0TJ, Griesmann\u00a0GE et al (2001) CRMP\u20115 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49:146\u2013154. https:\/\/doi.org\/10.1002\/1531-8249(20010201)49:2\u3008146::AID-ANA34\u30093.0.CO;2\u2011E","journal-title":"Ann Neurol"},{"key":"1092_CR108","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1055\/s-0038-1660856","volume":"38","author":"NL Zalewski","year":"2018","unstructured":"Zalewski\u00a0NL, Flanagan\u00a0EP (2018) Autoimmune and paraneoplastic myelopathies. Semin Neurol 38:278\u2013289. https:\/\/doi.org\/10.1055\/s-0038-1660856","journal-title":"Semin Neurol"},{"key":"1092_CR109","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000002992","volume":"87","author":"NL Zalewski","year":"2016","unstructured":"Zalewski\u00a0NL, Krecke\u00a0KN, Weinshenker\u00a0BG et\u00a0al (2016) Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology 87:743\u2013744. https:\/\/doi.org\/10.1212\/WNL.0000000000002992","journal-title":"Neurology"},{"key":"1092_CR110","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/jnnp-2016-314738","volume":"88","author":"NL Zalewski","year":"2017","unstructured":"Zalewski\u00a0NL, Morris\u00a0PP, Weinshenker\u00a0BG et al (2017) Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders. J\u00a0Neurol Neurosurg Psychiatry 88:218\u2013225. https:\/\/doi.org\/10.1136\/jnnp-2016-314738","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1092_CR111","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/1759-7714.13009","volume":"10","author":"A Zekeridou","year":"2019","unstructured":"Zekeridou\u00a0A, Majed\u00a0M, Heliopoulos\u00a0I, Lennon\u00a0VA (2019) Paraneoplastic autoimmunity and small-cell lung cancer: neurological and serological accompaniments. Thorac Cancer 10:1001\u20131004. https:\/\/doi.org\/10.1111\/1759-7714.13009","journal-title":"Thorac Cancer"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-021-01092-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-021-01092-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-021-01092-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T16:07:05Z","timestamp":1617811625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-021-01092-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s00115-021-01092-2","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"2 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0C.\u00a0Oertel: Forschungsgelder von der American Academy of Neurology\u00a0(AAN) und National Multiple Sclerosis Society (NMSS) (nicht im Zusammenhang mit diesem Artikel). M.\u00a0Scheel: keine externe Finanzierung. C.\u00a0Chien: Forschungsgelder von Novartis (nicht im Zusammenhang mit diesem Artikel). A.\u00a0Bischof: keine externe Finanzierung. C.\u00a0Finke: keine externe Finanzierung. F.\u00a0Paul: wissenschaftlicher Beirat f\u00fcr Novartis; Vortragshonorar\/Reisekosten von Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis\/Genzyme, Merck Serono, Alexion, Chugai, MedImmune, und Shire; akademischer Editor f\u00fcr PLoS ONE; Associate Editor f\u00fcr Neurology\u00ae Neuroimmunology & Neuroinflammation; wissenschaftliche Konsultation for SanofiGenzyme, Biogen Idec, MedImmune, Shire, und Alexion; Forschungsgelder von Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis\/Genzyme, Alexion, Merck Serono, Viela Bio, Deutsche Forschungsgemeinschaft, Werth Stiftung der Stadt K\u00f6ln, Deutsches Ministerium f\u00fcr Bildung und Forschung, Arthur Arnstein Stiftung Berlin, EU FP7 Framework Program, Arthur Arnstein Stiftung Berlin, Guthy Jackson Charitable Foundation, und National Multiple Sclerosis (USA) (nicht im Zusammenhang mit diesem Artikel).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}